Swiss biotech firm Alentis Therapeutics inks $105m Series C
Jeito Capital led the round with participation from other backers that included Novo Holdings A/S and RA Capital Management.
13 April 2023•1 min read
Jeito Capital led the round with participation from other backers that included Novo Holdings A/S and RA Capital Management.